Corvus Pharmaceuticals (CRVS) Other Non-Current Assets (2022 - 2025)
Historic Other Non-Current Assets for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $852000.0.
- Corvus Pharmaceuticals' Other Non-Current Assets rose 23809.52% to $852000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $852000.0, marking a year-over-year increase of 23809.52%. This contributed to the annual value of $632000.0 for FY2024, which is 61011.24% up from last year.
- Latest data reveals that Corvus Pharmaceuticals reported Other Non-Current Assets of $852000.0 as of Q3 2025, which was up 23809.52% from $626000.0 recorded in Q2 2025.
- In the past 5 years, Corvus Pharmaceuticals' Other Non-Current Assets ranged from a high of $852000.0 in Q3 2025 and a low of $89000.0 during Q3 2023
- In the last 4 years, Corvus Pharmaceuticals' Other Non-Current Assets had a median value of $236000.0 in 2022 and averaged $299600.0.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 6411.29% in 2023, then soared by 61011.24% in 2024.
- Quarter analysis of 4 years shows Corvus Pharmaceuticals' Other Non-Current Assets stood at $129000.0 in 2022, then crashed by 31.01% to $89000.0 in 2023, then surged by 610.11% to $632000.0 in 2024, then skyrocketed by 34.81% to $852000.0 in 2025.
- Its last three reported values are $852000.0 in Q3 2025, $626000.0 for Q2 2025, and $629000.0 during Q1 2025.